Sale!

PRPH2 Gene Choroidal Dystrophy Central Areolar Type 2 Genetic Test

3,200 د.إ

-43%

The PRPH2 Gene Choroidal Dystrophy Central Areolar Type 2 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the PRPH2 gene, which are linked to the development of Central Areolar Choroidal Dystrophy Type 2 (CACD2). This condition is a rare, inherited eye disorder that affects the central area of the retina, leading to progressive vision loss. The test is crucial for early detection and management of the disease, offering insights into potential treatment paths and helping in family planning decisions. Conducted at the state-of-the-art facilities of DNA Labs UAE, the test cost is set at 3200 AED. This genetic testing is a significant step towards personalized medicine, providing patients and their families with crucial information about their genetic health and predisposition to this specific form of choroidal dystrophy.

Home  Sample collection service available

  • 100% accuaret DNA Results
  • Ranked as Most trusted Genetic DNA Lab
Guaranteed Safe Checkout

PRPH2 Gene Choroidal Dystrophy Central Areolar Type 2 Genetic Test

Are you or a loved one at risk of developing central areolar choroidal dystrophy type 2? DNA Labs UAE offers the PRPH2 Gene Choroidal Dystrophy Central Areolar Type 2 Genetic Test to help diagnose and provide information about the genetic cause of this condition.

Test Details

The PRPH2 gene choroidal dystrophy, central areolar type 2 NGS genetic test is a diagnostic test that utilizes next-generation sequencing technology to analyze the PRPH2 gene for mutations or variations associated with central areolar choroidal dystrophy type 2. This test confirms a clinical diagnosis of the condition and provides information about its genetic cause.

Components

  • Test Name: PRPH2 Gene Choroidal Dystrophy Central Areolar Type 2 Genetic Test
  • Price: 3200.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Ophthalmology Disorders
  • Doctor: Ophthalmologist
  • Test Department: Genetics

Symptoms and Diagnosis

Central areolar choroidal dystrophy type 2 is an inherited retinal disorder that affects the central vision. The PRPH2 Gene Choroidal Dystrophy Central Areolar Type 2 Genetic Test helps identify individuals who are at risk of developing the disease. It also provides valuable information for genetic counseling and family planning.

Pre Test Information

Before undergoing the PRPH2 Gene Choroidal Dystrophy Central Areolar Type 2 Genetic Test, it is important to provide the clinical history of the patient. A genetic counseling session will be conducted to draw a pedigree chart of family members affected with PRPH2 Gene Choroidal Dystrophy Central Areolar Type 2.

Don’t wait until it’s too late. Take control of your health and get tested today!

Test Name PRPH2 Gene Choroidal dystrophy central areolar type 2 Genetic Test
Components
Price 3200.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ophthalmology Disorders
Doctor Ophthalmologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PRPH2 Gene Choroidal dystrophy, central areolar type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PRPH2 Gene Choroidal dystrophy, central areolar type 2 NGS Genetic DNA Test gene PRPH2
Test Details

PRPH2 gene choroidal dystrophy, central areolar type 2 NGS genetic test is a diagnostic test that uses next-generation sequencing technology to analyze the PRPH2 gene for mutations or variations that are associated with central areolar choroidal dystrophy type 2. This test is used to confirm a clinical diagnosis of the condition and to provide information about the genetic cause of the disease. Central areolar choroidal dystrophy type 2 is an inherited retinal disorder that affects the central vision and is caused by mutations in the PRPH2 gene. The NGS genetic test can help identify individuals who are at risk of developing the disease and can provide information for genetic counseling and family planning.